Vimarsana
Biggest News Aggregation in the World

Royw Beck News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Royw Beck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Royw Beck Today - Breaking & Trending Today

FDA Clears iLet Bionic Pancreas Insulin Delivery System - Vimarsana News

FDA Clears iLet Bionic Pancreas Insulin Delivery System

The FDA has cleared a next-generation insulin pump and software combination that provides greater automation than current "artificial pancreas" systems.

Control-IQ Technology Linked to Improved Glycemic Control, Regardless of Patient Age - Vimarsana News

Control-IQ Technology Linked to Improved Glycemic Control, Regardless of Patient Age

A meta-analysis of trials examining use of the t:slim X2 insulin pump with Control-IQ technology, results of the study indicate use of the hybrid closed loop technology was associated with improvements in glycemic control, regardless of patient age, race, or previous CGM use.

Control-IQ artificial pancreas system improves blood sugar control for both kids, adults with type 1 diabetes - Vimarsana News

Control-IQ artificial pancreas system improves blood sugar control for both kids, adults with type 1 diabetes

An artificial pancreas developed at the University of Virginia Center for Diabetes Technology improves blood sugar control for people ages 2 to 72 with type 1 diabetes, according to a new combined analysis of three clinical trials.

Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes - Vimarsana News

Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes

Tandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, today announced publication by Diabetes Technology & Therapeutics of a meta-analysis of three randomized... | April 17, 2023

Intensive diabetes management does not preserve C-peptide in youths with type 1 diabetes - Vimarsana News

Intensive diabetes management does not preserve C-peptide in youths with type 1 diabetes

Older children with newly diagnosed type 1 diabetes who received intensive diabetes management with automated insulin delivery had no difference in pancreatic C-peptide levels compared with standard care, according to study data. “Achieving excellent glycemic control soon after diagnosis of type 1 diabetes was unsuccessful in preventing the progressive loss of insulin production by the

Source: healio.com